Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT05817500
Collaborator
(none)
40
1
12
3.3

Study Details

Study Description

Brief Summary

The aim of this study is to assess the possibility of discussing advance directives during post-intensive care consultation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    After a stay in intensive care units (ICU), patients can experience physical, psychological and cognitive impairments. To assess this post intensive care syndrom (PICS), post-ICU consultation have been developed.

    Since 5 year mortality is higher in ICU survivors, it might be interesting to address those patients' views relating to illness and end of life through a discussion on advance directives (AD), during post-ICU consultation.

    However, the development of these consultations being recent, it has not yet been assessed whether this consultations might be a suitable time to discuss AD and the intensivit a suitable interlocutor.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Post-ICU Consultation : a Time to Discuss Advance Directives
    Actual Study Start Date :
    Dec 9, 2021
    Actual Primary Completion Date :
    Dec 9, 2022
    Actual Study Completion Date :
    Dec 9, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    ICU patients with > 48h mechanical ventilation and/or > 5 days stay in ICU

    Outcome Measures

    Primary Outcome Measures

    1. Number of patients willing to discuss AD after an ICU stay [1 year]

      Number of patient willing to discussion AD after ICU stay will be observed

    Secondary Outcome Measures

    1. Number of patients knowing about AD before their ICU stay [1 year]

      Number of patient knowing before AD before ICU stay will be observed

    2. Factors influencing the writing of AD after an ICU stay [1 year]

      Factors such as lenght of stay in ICU, lenght of hospitalisation, duration of mechanical ventilation /sedation and the existence of PTSD (PCLS) or anxiety/ depression (HADS) will be evaluated and their influence on the completion of AD

    3. Evaluation of the privileged interlocutor to discuss AD [1 year]

      The privileged interlocutor to discuss AD will be observed

    4. Evaluation of the privileged interlocutor to complete AD [1 year]

      The privileged interlocutor to complete AD will be observed

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with 48 hours of mechanical ventilation

    • Patients with a 5 days stay in ICU

    Exclusion Criteria:
    • Patients with therapeutic limitation discussed during their ICU stay

    • Geographical remotness to come to the post-ICU consultation

    • Minor patients

    • Patient not affiliated to the social security scheme

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU Brest Brest France 29200

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT05817500
    Other Study ID Numbers:
    • 29BRC21.0335 - CoPRADA
    First Posted:
    Apr 18, 2023
    Last Update Posted:
    Apr 18, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Brest
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 18, 2023